BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38841851)

  • 1. Genomic Landscape of Adenocarcinomas Across the Gastroesophageal Junction: Moving on from the Siewert Classification.
    Nakauchi M; Walch HS; Nussenzweig S; Carr R; Vos E; Berger MF; Schultz N; Janjigian Y; Wu A; Tang L; Shah P; Jones DR; Coit D; Strong VE; Molena D; Sihag S
    Ann Surg; 2024 Jun; ():. PubMed ID: 38841851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the distinct genomic features in gastroesophageal junction adenocarcinoma and its Siewert subtypes.
    Geng Q; Lao J; Zuo X; Chen S; Bei JX; Xu D
    J Pathol; 2020 Nov; 252(3):263-273. PubMed ID: 32715475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CT in differentiation of cT3 and cT4a Siewert type II esophagogastric junction adenocarcinoma: A comparison study based on UICC/AJCC 8th edition and IGCA 4th edition].
    Fu J; Tang L; Li Z; Li X; Zhang Y; Gao S; Sun Y; Ji J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1013-1018. PubMed ID: 30269321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas.
    van Dekken H; Geelen E; Dinjens WN; Wijnhoven BP; Tilanus HW; Tanke HJ; Rosenberg C
    Cancer Res; 1999 Feb; 59(3):748-52. PubMed ID: 9973227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinicopathologic characteristics and prognostic factors of gastroesophageal junction tumors according to Siewert classification.
    Ustaalioğlu BBÖ; Tilki M; Sürmelioğlu A; Bilici A; Gönen C; Ustaalioğlu R; Balvan Ö; Aliustaoğlu M
    Turk J Surg; 2017; 33(1):18-24. PubMed ID: 28589183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in prognosis of Siewert II and III oesophagogastric junction cancers are determined by the baseline tumour staging but not its anatomical location.
    Kulig P; Sierzega M; Pach R; Kolodziejczyk P; Kulig J;
    Eur J Surg Oncol; 2016 Aug; 42(8):1215-21. PubMed ID: 27241921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophagogastric junction adenocarcinoma shares characteristics with gastric adenocarcinoma: Literature review and retrospective multicenter cohort study.
    Imamura Y; Watanabe M; Oki E; Morita M; Baba H
    Ann Gastroenterol Surg; 2021 Jan; 5(1):46-59. PubMed ID: 33532680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical pathology of adenocarcinomas arising around or within the gastroesophageal junction.
    Dislich B; Kröll D; Langer R
    Updates Surg; 2023 Feb; 75(2):395-402. PubMed ID: 36001283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: A comparative analysis according to Siewert classification in a Japanese cohort.
    Urabe M; Ushiku T; Shinozaki-Ushiku A; Iwasaki A; Yamazawa S; Yamashita H; Seto Y; Fukayama M
    Cancer Med; 2018 Oct; 7(10):5145-5154. PubMed ID: 30239168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopathological patterns of the stomach in adenocarcinoma of the esophagus, cardia, and gastric antrum: gastric profiles in Siewert type I and II tumors.
    Mattioli S; Ruffato A; Di Simone MP; Corti B; D'Errico A; Lugaresi ML; Mattioli B; D'Ovidio F
    Ann Thorac Surg; 2007 May; 83(5):1814-9. PubMed ID: 17462405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Barrett's metaplasia the source of adenocarcinomas of the cardia?
    Clark GW; Smyrk TC; Burdiles P; Hoeft SF; Peters JH; Kiyabu M; Hinder RA; Bremner CG; DeMeester TR
    Arch Surg; 1994 Jun; 129(6):609-14. PubMed ID: 8204035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomically Stable Gastric Cancer Characterized by Hypomethylation in Wnt Signal Cascade.
    Toshima T; Tanioka H; Mori Y; Tanaka T; Yasui K; Kimura K; Umeda Y; Fujiwara T; Nyuya A; Yano S; Nagasaka T
    Oncology; 2023; 101(2):105-116. PubMed ID: 36244328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological features of Siewert type II adenocarcinoma: comparison of gastric cardia adenocarcinoma and Barrett's esophageal adenocarcinoma following endoscopic submucosal dissection.
    Osumi H; Fujisaki J; Omae M; Shimizu T; Yoshio T; Ishiyama A; Hirasawa T; Tsuchida T; Yamamoto Y; Kawachi H; Yamamoto N; Igarashi M
    Gastric Cancer; 2017 Jul; 20(4):663-670. PubMed ID: 27783167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Incidence Trend of Surgically Resected Esophagogastric Junction Adenocarcinoma and Microsatellite Instability Status in Japanese Patients.
    Imamura Y; Watanabe M; Toihata T; Takamatsu M; Kawachi H; Haraguchi I; Ogata Y; Yoshida N; Saeki H; Oki E; Taguchi K; Yamamoto M; Morita M; Mine S; Hiki N; Baba H; Sano T
    Digestion; 2019; 99(1):6-13. PubMed ID: 30554205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contemporary outcomes for resected type 1-3 gastroesophageal junction adenocarcinoma: a single-center experience.
    Stiles ZE; Hagerty BL; Brady M; Mukherjee S; Hochwald SN; Kukar M
    J Gastrointest Surg; 2024 May; 28(5):634-639. PubMed ID: 38704200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Esophagogastric junction cancer in the TNM classification].
    Yoshikawa T
    Nihon Geka Gakkai Zasshi; 2015 Jan; 116(1):35-9. PubMed ID: 25842811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinicopathologic comparison of Siewert type II and III adenocarcinomas of the gastroesophageal junction.
    Yuasa N; Miyake H; Yamada T; Ebata T; Nimura Y; Hattori T
    World J Surg; 2006 Mar; 30(3):364-71. PubMed ID: 16485063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of esophago-gastric junction adenocarcinoma.
    de Manzoni G; Zanoni A; Giacopuzzi S
    Ann Ital Chir; 2012; 83(3):208-14. PubMed ID: 22595732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p53 protein in Barrett's adenocarcinoma and adenocarcinoma of the gastric cardia and antrum.
    Jovanović I; Todorović V; Milosavljević T; Micev M; Pesko P; Bjelović M; Mouzas Y; Tzardi M
    Vojnosanit Pregl; 2005 Dec; 62(12):879-85. PubMed ID: 16375215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.